SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
BioAge Labs, Inc. (BIOA) has a negative trailing P/E of -7.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -13.03%.
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+156.5%).
- Trailing Earnings Yield -13.03% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
- Analyst consensus target $42.50 (+156.5% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 45/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BIOA
Valuation Multiples
P/E (TTM)-7.7
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio2.27
P/S Ratio68.88
EV/EBITDA-5.3
Per Share Data
EPS (TTM)$-2.24
Book Value / Share$7.57
Revenue / Share$0.25
FCF / Share$-2.29
Yields & Fair Value
Earnings Yield-13.03%
Dividend Yield0.00%
Analyst Target$42.50 (+156.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2022 |
-3.4 |
0.00 |
-1.21 |
0.00 |
- |
| 2023 |
-2.1 |
-0.04 |
-0.79 |
0.00 |
- |
| 2024 |
-0.9 |
0.04 |
0.19 |
0.00 |
- |
| 2025 |
-5.9 |
0.09 |
1.75 |
52.85 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2022 |
$-5.32 |
$0.00 |
$-39.72M |
- |
| 2023 |
$-8.55 |
$0.00 |
$-63.85M |
- |
| 2024 |
$-6.63 |
$0.00 |
$-71.11M |
- |
| 2025 |
$-2.24 |
$9M |
$-80.61M |
-896.1% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-2.62 |
$-3.03 – $-2.29 |
$4.54M |
$632.94K – $14.05M |
4 |
| 2027 |
$-2.24 |
$-2.66 – $-1.49 |
$19.11M |
$950.22K – $37.26M |
5 |
| 2028 |
$-2.85 |
$-3.61 – $-2.43 |
$2.01M |
$279.78K – $6.21M |
6 |
| 2029 |
$-3.40 |
$-12.68 – $0.40 |
$4.35M |
$606.81K – $13.47M |
4 |
| 2030 |
$-3.92 |
$-14.62 – $0.47 |
$4.69M |
$654.06K – $14.52M |
2 |
